TECLISTAMAB-CQYV

TECLISTAMAB-CQYV was reported 2379 times

TECLISTAMAB-CQYV is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NEWCASTLE DISEASE 3 0.7500
1 HERPETIC RADICULOPATHY 1 0.1250
2 PREMEDICATION 1 0.1111
3 PNEUMONIA PROTEUS 1 0.1000
4 MONONUCLEAR CELL COUNT INCREASED 1 0.0909
5 CAMPYLOBACTER TEST POSITIVE 6 0.0789
6 IVTH NERVE PARALYSIS 17 0.0717
7 HEPATITIS B SURFACE ANTIGEN 1 0.0714
8 ALBUMIN CSF INCREASED 1 0.0667
9 ALLERGIC GASTROENTERITIS 1 0.0625
10 MULTISYSTEM INFLAMMATORY SYNDROME IN ADULTS 1 0.0556
11 PULMONARY LYMPHOMATOID GRANULOMATOSIS 1 0.0476
12 IMMUNOSUPPRESSANT DRUG THERAPY 1 0.0455
13 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 211 0.0356
14 CAMPYLOBACTER BACTERAEMIA 1 0.0333
15 SAPOVIRUS INFECTION 1 0.0312
16 PARVOVIRUS B19 INFECTION REACTIVATION 1 0.0312
17 LYMPHODEPLETION 1 0.0294
18 LIGHT CHAIN ANALYSIS DECREASED 2 0.0290
19 CYTOKINE RELEASE SYNDROME 582 0.0290
20 FUNGAL MYOSITIS 1 0.0286
21 LOCOMOTIVE SYNDROME 1 0.0270
22 PARVIMONAS MICRA INFECTION 1 0.0244
23 CALCULUS PROSTATIC 1 0.0222
24 PROSTATITIS ESCHERICHIA COLI 1 0.0200
25 MALIGNANT SWEAT GLAND NEOPLASM 1 0.0185
26 JC VIRUS CSF TEST POSITIVE 1 0.0182
27 HAEMOPHILUS SEPSIS 1 0.0175
28 COMPLICATED FRACTURE 1 0.0161
29 PLASMA CELLS INCREASED 1 0.0137
30 PLASMA CELL LEUKAEMIA 8 0.0133
31 PNEUMONIA MORAXELLA 1 0.0132
32 RECTAL SPASM 3 0.0130
33 GASTROENTERITIS ASTROVIRAL 1 0.0125
34 RADIATION INFLAMMATION 1 0.0125
35 ALEXIA 1 0.0123
36 SARCOMA OF SKIN 1 0.0123
37 CAMPYLOBACTER COLITIS 1 0.0116
38 GASTROENTERITIS SAPOVIRUS 1 0.0115
39 KLEBSIELLA URINARY TRACT INFECTION 3 0.0113
40 BORDETELLA INFECTION 1 0.0111
41 GENITOURINARY TRACT INFECTION 3 0.0106
42 IGA NEPHROPATHY 17 0.0102
43 CAMPYLOBACTER GASTROENTERITIS 6 0.0101
44 COMPUTERISED TOMOGRAM HEAD ABNORMAL 1 0.0101
45 PARAINFLUENZA VIRUS INFECTION 1 0.0097
46 LIGHT CHAIN ANALYSIS ABNORMAL 2 0.0096
47 OBSTRUCTIVE SHOCK 1 0.0092
48 HYPOGLOBULINAEMIA 1 0.0088
49 TUMOUR FLARE 6 0.0088
50 SWEAT GLAND TUMOUR 2 0.0085
51 PLASMA CELL MYELOMA REFRACTORY 11 0.0082
52 NEISSERIA INFECTION 1 0.0079
53 EPIDURAL HAEMORRHAGE 1 0.0077
54 HYPOGAMMAGLOBULINAEMIA 50 0.0076
55 NEUROBORRELIOSIS 1 0.0076
56 CRANIAL NERVE PALSIES MULTIPLE 1 0.0071
57 MONOCLONAL IMMUNOGLOBULIN INCREASED 2 0.0070
58 HYPERVISCOSITY SYNDROME 2 0.0069
59 INTERVERTEBRAL DISCITIS 13 0.0069
60 NAIL TOXICITY 2 0.0067
61 IMMUNE EFFECTOR CELL-ASSOCIATED HLH-LIKE SYNDROME 1 0.0066
62 ENTEROBACTER BACTERAEMIA 2 0.0066
63 APOPTOSIS 2 0.0065
64 ALLOGENIC STEM CELL TRANSPLANTATION 1 0.0063
65 HAEMOPHILUS INFECTION 6 0.0061
66 CYTOMEGALOVIRUS SYNDROME 1 0.0061
67 CYSTITIS KLEBSIELLA 1 0.0060
68 LIGHT CHAIN ANALYSIS INCREASED 6 0.0058
69 PANCREATIC DUCT OBSTRUCTION 1 0.0056
70 BLOOD BILIRUBIN UNCONJUGATED INCREASED 4 0.0055
71 ACUTE HEPATITIS C 1 0.0055
72 METASTASES TO NERVOUS SYSTEM 1 0.0054
73 ACINETOBACTER BACTERAEMIA 1 0.0053
74 PSEUDOMONAL SEPSIS 9 0.0051
75 COOMBS NEGATIVE HAEMOLYTIC ANAEMIA 1 0.0051
76 PNEUMONIA ADENOVIRAL 1 0.0051
77 SUPERINFECTION BACTERIAL 4 0.0050
78 HAPTOGLOBIN DECREASED 4 0.0050
79 PARVOVIRUS INFECTION 2 0.0050
80 ADENOCARCINOMA METASTATIC 1 0.0049
81 SALMONELLA BACTERAEMIA 1 0.0048
82 RADIATION ASSOCIATED PAIN 1 0.0048
83 GASTROENTERITIS SALMONELLA 4 0.0048
84 PRODUCT ADMINISTRATION ISSUE 1 0.0048
85 PSEUDOMONAL BACTERAEMIA 4 0.0047
86 ENTEROVIRUS INFECTION 4 0.0046
87 ENCEPHALITIS CYTOMEGALOVIRUS 2 0.0046
88 CARDIAC AMYLOIDOSIS 5 0.0045
89 DERMATITIS PSORIASIFORM 9 0.0044
90 IMMUNOGLOBULINS DECREASED 6 0.0044
91 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 36 0.0044
92 BREAKTHROUGH COVID-19 1 0.0043
93 INCREASED NEED FOR SLEEP 1 0.0043
94 OLIGODIPSIA 1 0.0043
95 STEREOTYPY 4 0.0042
96 SALMONELLA SEPSIS 1 0.0042
97 EAR NEOPLASM MALIGNANT 1 0.0042
98 SALMONELLOSIS 7 0.0041
99 PALMOPLANTAR KERATODERMA 3 0.0041
100 SYPHILIS 3 0.0041
101 CYTOMEGALOVIRUS INFECTION REACTIVATION 18 0.0041
102 CYTOPENIA 48 0.0039
103 HERPES ZOSTER REACTIVATION 1 0.0038
104 PLASMACYTOMA 7 0.0038
105 PRODUCT NAME CONFUSION 4 0.0037
106 PSEUDOMONAS TEST POSITIVE 3 0.0037
107 MORAXELLA INFECTION 1 0.0036
108 PRODUCT SELECTION ERROR 4 0.0036
109 BLOOD IMMUNOGLOBULIN G DECREASED 9 0.0036
110 INTERLEUKIN LEVEL INCREASED 2 0.0036
111 ANAEMIA OF MALIGNANT DISEASE 1 0.0036
112 CYTOMEGALOVIRUS TEST POSITIVE 6 0.0034
113 CYTOMEGALOVIRUS GASTROINTESTINAL INFECTION 1 0.0034
114 DERMO-HYPODERMITIS 2 0.0034
115 PLASMA CELL MYELOMA 131 0.0034
116 HEPATIC ISCHAEMIA 1 0.0032
117 MUSCLE TONE DISORDER 1 0.0032
118 CHRONIC HEPATITIS B 1 0.0032
119 BACTERIAL TRANSLOCATION 1 0.0032
120 ASPERGILLOMA 1 0.0031
121 JC VIRUS INFECTION 5 0.0031
122 PNEUMONIA CYTOMEGALOVIRAL 6 0.0031
123 CYTOMEGALOVIRUS CHORIORETINITIS 6 0.0031
124 HYPERCREATINAEMIA 1 0.0030
125 GIARDIASIS 1 0.0029
126 PNEUMONITIS CHEMICAL 1 0.0029
127 PLASMABLASTIC LYMPHOMA 1 0.0028
128 CEREBRAL MASS EFFECT 1 0.0028
129 ABSCESS BACTERIAL 1 0.0028
130 ENTEROBACTER SEPSIS 1 0.0027
131 KLEBSIELLA SEPSIS 3 0.0027
132 HERPES SIMPLEX REACTIVATION 1 0.0026
133 CYTOMEGALOVIRUS COLITIS 6 0.0026
134 ADMINISTRATION SITE REACTION 1 0.0026
135 PRODUCT BARCODE ISSUE 1 0.0026
136 METAPNEUMOVIRUS INFECTION 2 0.0026
137 MENINGEAL DISORDER 1 0.0025
138 ACUTE LEUKAEMIA 4 0.0025
139 SECONDARY IMMUNODEFICIENCY 3 0.0025
140 ENCEPHALITIS VIRAL 3 0.0025
141 HIGH FREQUENCY ABLATION 1 0.0025
142 AORTIC OCCLUSION 1 0.0024
143 POST-ACUTE COVID-19 SYNDROME 3 0.0024
144 RHINOVIRUS INFECTION 9 0.0023
145 OESOPHAGEAL INFECTION 1 0.0022
146 HEPATITIS B REACTIVATION 7 0.0022
147 EATING DISORDER SYMPTOM 1 0.0022
148 PRE-EXISTING DISEASE 1 0.0021
149 MOTOR NEURONE DISEASE 1 0.0021
150 NEUROENDOCRINE CARCINOMA OF THE SKIN 2 0.0020
151 ADVERSE REACTION 27 0.0020
152 DERMATITIS INFECTED 1 0.0020
153 PARAINFLUENZAE VIRUS INFECTION 3 0.0020
154 INFECTIOUS PLEURAL EFFUSION 3 0.0020
155 PALLIATIVE CARE 3 0.0020
156 LOWER RESPIRATORY TRACT INFECTION BACTERIAL 1 0.0020
157 PNEUMONIA PSEUDOMONAL 3 0.0020
158 AORTIC VALVE CALCIFICATION 1 0.0019
159 NEUROTOXICITY 34 0.0019
160 GLOMERULONEPHRITIS MEMBRANOPROLIFERATIVE 1 0.0019
161 CRYPTOSPORIDIOSIS INFECTION 1 0.0019
162 SCLERITIS 3 0.0019
163 BLOOD IMMUNOGLOBULIN A INCREASED 1 0.0019
164 TOXOPLASMOSIS 2 0.0019
165 LISTERIOSIS 2 0.0018
166 HYPERTENSIVE URGENCY 1 0.0018
167 NAIL DYSTROPHY 1 0.0018
168 NEUTROPHIL COUNT ABNORMAL 5 0.0018
169 BURNING MOUTH SYNDROME 1 0.0018
170 BLADDER NEOPLASM 3 0.0018
171 BLOOD FIBRINOGEN DECREASED 2 0.0018
172 MECHANICAL ILEUS 1 0.0018
173 T-CELL LYMPHOMA 2 0.0017
174 LARYNGEAL STENOSIS 1 0.0017
175 FEBRILE INFECTION 2 0.0017
176 PNEUMOCOCCAL INFECTION 1 0.0017
177 ACIDOSIS HYPERCHLORAEMIC 1 0.0017
178 TRANSPLANT 4 0.0017
179 ESCHERICHIA TEST POSITIVE 2 0.0017
180 SOFT TISSUE INFECTION 3 0.0016
181 HAEMATOLOGICAL INFECTION 4 0.0016
182 LARGE INTESTINE INFECTION 2 0.0016
183 TUMOUR LYSIS SYNDROME 14 0.0016
184 PNEUMONIA VIRAL 5 0.0016
185 ACTIVITIES OF DAILY LIVING DECREASED 1 0.0016
186 NECROTISING RETINITIS 1 0.0016
187 PLATELET TRANSFUSION 2 0.0016
188 CHORIORETINITIS 1 0.0016
189 PNEUMONIA NECROTISING 1 0.0015
190 MAGNETIC RESONANCE IMAGING HEAD ABNORMAL 1 0.0015
191 REFLEXES ABNORMAL 1 0.0015
192 KLEBSIELLA TEST POSITIVE 1 0.0015
193 CELLULITIS STAPHYLOCOCCAL 1 0.0015
194 TUMOUR PAIN 2 0.0015
195 EMPYEMA 3 0.0015
196 RENAL VEIN THROMBOSIS 1 0.0015
197 ABSCESS NECK 1 0.0015
198 HEAD AND NECK CANCER 1 0.0015
199 MUSCLE CONTRACTURE 3 0.0015
200 CENTRAL SEROUS CHORIORETINOPATHY 1 0.0015
201 PLEURAL THICKENING 1 0.0015
202 RESPIRATORY TRACT INFECTION 38 0.0015
203 NEUROENDOCRINE CARCINOMA 1 0.0014
204 VIRAEMIA 2 0.0014
205 FUSARIUM INFECTION 1 0.0014
206 INTENSIVE CARE 2 0.0014
207 GASTRIC MUCOSAL LESION 1 0.0014
208 BRAIN STEM SYNDROME 1 0.0013
209 SUPERINFECTION 2 0.0013
210 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 10 0.0013
211 CYTOMEGALOVIRUS ENTEROCOLITIS 1 0.0013
212 GRIMACING 1 0.0013
213 PRODUCT INEFFECTIVE 1 0.0013
214 DIARRHOEA INFECTIOUS 1 0.0013
215 HEPATITIS E 2 0.0013
216 HERPES ZOSTER DISSEMINATED 1 0.0012
217 ABDOMINAL SYMPTOM 1 0.0012
218 IIIRD NERVE PARALYSIS 1 0.0012
219 CLOSTRIDIUM DIFFICILE COLITIS 13 0.0012
220 RESORPTION BONE INCREASED 1 0.0012
221 ERYTHRODERMIC PSORIASIS 1 0.0012
222 GENITAL INFECTION FUNGAL 1 0.0012
223 HAND-FOOT-AND-MOUTH DISEASE 1 0.0012
224 HYPOPYON 1 0.0012
225 DYSCHROMATOPSIA 1 0.0012
226 CYTOMEGALOVIRUS INFECTION 20 0.0012
227 INFUSION SITE OEDEMA 1 0.0012
228 ENTEROBACTER INFECTION 2 0.0012
229 HYPERPYREXIA 5 0.0012
230 BACTERAEMIA 14 0.0012
231 AMYLOIDOSIS 2 0.0012
232 INFUSION SITE DISCOLOURATION 1 0.0011
233 HYPERLEUKOCYTOSIS 1 0.0011
234 PARVOVIRUS B19 INFECTION 1 0.0011
235 MYCOBACTERIUM AVIUM COMPLEX INFECTION 3 0.0011
236 OPHTHALMIC HERPES ZOSTER 2 0.0011
237 PNEUMOCYSTIS JIROVECII PNEUMONIA 11 0.0011
238 GASTRIC OPERATION 1 0.0011
239 IMMUNE-MEDIATED ENTEROCOLITIS 4 0.0011
240 OPPORTUNISTIC INFECTION 2 0.0011
241 ADENOCARCINOMA OF COLON 2 0.0011
242 NASAL OBSTRUCTION 2 0.0011
243 PNEUMONIA CRYPTOCOCCAL 1 0.0011
244 KLEBSIELLA BACTERAEMIA 1 0.0011
245 INTUSSUSCEPTION 1 0.0010
246 GASTROINTESTINAL TOXICITY 5 0.0010
247 PYELONEPHRITIS 9 0.0010
248 ADENOVIRUS INFECTION 3 0.0010
249 ABDOMINAL WALL HAEMATOMA 2 0.0010
250 ENCEPHALITIS 7 0.0010
251 HYPOFIBRINOGENAEMIA 1 0.0010
252 CAROTID ARTERIOSCLEROSIS 1 0.0010
253 CAPILLARY LEAK SYNDROME 2 0.0010
254 VARICELLA ZOSTER VIRUS INFECTION 2 0.0010
255 INFUSION SITE PRURITUS 3 0.0009
256 IRIDOCYCLITIS 3 0.0009
257 INFECTION 136 0.0009
258 PSEUDOMONAS INFECTION 8 0.0009
259 COVID-19 PNEUMONIA 11 0.0009
260 INFUSION SITE BRUISING 2 0.0009
261 PLASMA CELL MYELOMA RECURRENT 3 0.0009
262 BACTERIAL SEPSIS 3 0.0009
263 NAIL DISORDER 8 0.0009
264 ASPERGILLUS INFECTION 6 0.0009
265 PNEUMONIA STREPTOCOCCAL 1 0.0009
266 BRONCHOPULMONARY ASPERGILLOSIS 7 0.0009
267 CYTOMEGALOVIRUS VIRAEMIA 4 0.0009
268 TOXIC SKIN ERUPTION 9 0.0009
269 PULMONARY GRANULOMA 1 0.0009
270 INFECTION REACTIVATION 1 0.0009
271 CENTRAL NERVOUS SYSTEM INFECTION 1 0.0009
272 PNEUMONIA BACTERIAL 8 0.0009
273 METASTATIC MALIGNANT MELANOMA 2 0.0009
274 DYSLEXIA 1 0.0009
275 UROSEPSIS 8 0.0009
276 ISCHAEMIC CEREBRAL INFARCTION 1 0.0009
277 NEUTROPENIA 116 0.0009
278 BRONCHIOLITIS 3 0.0009
279 ESCHERICHIA INFECTION 7 0.0009
280 NECROTISING FASCIITIS 3 0.0009
281 HYPERTENSIVE EMERGENCY 1 0.0008
282 COCCIDIOIDOMYCOSIS 1 0.0008
283 PNEUMOCYSTIS JIROVECII INFECTION 1 0.0008
284 MULTIMORBIDITY 1 0.0008
285 CLOSTRIDIUM COLITIS 1 0.0008
286 PRODUCT PACKAGING CONFUSION 2 0.0008
287 BLOOD IMMUNOGLOBULIN G INCREASED 1 0.0008
288 INFUSION SITE WARMTH 1 0.0008
289 FRACTURED SACRUM 1 0.0008
290 RECTAL TENESMUS 1 0.0008
291 STEM CELL TRANSPLANT 2 0.0008
292 REHABILITATION THERAPY 3 0.0008
293 PNEUMONIA FUNGAL 3 0.0008
294 HERPES OPHTHALMIC 1 0.0008
295 INTERCEPTED PRODUCT PRESCRIBING ERROR 1 0.0008
296 OESOPHAGEAL CANDIDIASIS 3 0.0008
297 COLITIS 28 0.0007
298 B-LYMPHOCYTE COUNT DECREASED 1 0.0007
299 TENOSYNOVITIS 2 0.0007
300 LUNG CONSOLIDATION 2 0.0007
301 ONYCHOMADESIS 3 0.0007
302 PRODUCT EXPIRATION DATE ISSUE 1 0.0007
303 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 1 0.0007
304 SKIN TOXICITY 4 0.0007
305 ATYPICAL MYCOBACTERIAL INFECTION 1 0.0007
306 ESCHERICHIA URINARY TRACT INFECTION 3 0.0007
307 GLUTEN SENSITIVITY 1 0.0007
308 SEPTIC SHOCK 30 0.0007
309 PULMONARY SEPSIS 1 0.0007
310 NORMOCYTIC ANAEMIA 1 0.0007
311 PNEUMONIA PNEUMOCOCCAL 1 0.0007
312 HEPATITIS FULMINANT 2 0.0007
313 GASTROINTESTINAL INFECTION 6 0.0007
314 TRANSFUSION 7 0.0007
315 BLOOD CULTURE POSITIVE 2 0.0007
316 MENTAL FATIGUE 1 0.0007
317 LUNG ADENOCARCINOMA 2 0.0007
318 FULL BLOOD COUNT ABNORMAL 7 0.0007
319 MARASMUS 1 0.0007
320 HYPERCALCAEMIA 8 0.0006
321 MYELITIS 1 0.0006
322 BRONCHIAL DISORDER 1 0.0006
323 INJECTION SITE HYPERSENSITIVITY 2 0.0006
324 INFUSION SITE SWELLING 4 0.0006
325 PNEUMONIA LEGIONELLA 1 0.0006
326 GUILLAIN-BARRE SYNDROME 3 0.0006
327 DECREASED IMMUNE RESPONSIVENESS 6 0.0006
328 HOSPICE CARE 6 0.0006
329 DYSGRAPHIA 4 0.0006
330 INJECTION RELATED REACTION 1 0.0006
331 SUSPECTED COVID-19 2 0.0006
332 OTITIS MEDIA 2 0.0006
333 IMMUNODEFICIENCY 9 0.0006
334 INTERCEPTED PRODUCT DISPENSING ERROR 1 0.0006
335 CLOSTRIDIUM DIFFICILE INFECTION 13 0.0006
336 MALIGNANT PLEURAL EFFUSION 1 0.0006
337 BK VIRUS INFECTION 2 0.0006
338 GENERAL PHYSICAL CONDITION ABNORMAL 4 0.0006
339 BACTERIAL INFECTION 11 0.0006
340 INJECTION SITE RASH 18 0.0006
341 INJECTION SITE OEDEMA 1 0.0006
342 RETINITIS 1 0.0006
343 MEDICAL DEVICE REMOVAL 1 0.0006
344 FAILURE TO THRIVE 3 0.0006
345 RESPIRATORY SYNCYTIAL VIRUS INFECTION 5 0.0006
346 SERUM FERRITIN INCREASED 3 0.0006
347 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 1 0.0006
348 INDURATION 1 0.0006
349 BONE LESION 2 0.0006
350 PRODUCT PRESCRIBING ISSUE 12 0.0006
351 NEUROPATHY PERIPHERAL 52 0.0005
352 PUPILLARY REFLEX IMPAIRED 1 0.0005
353 ACUTE PULMONARY OEDEMA 3 0.0005
354 CHRONIC SINUSITIS 2 0.0005
355 STATUS EPILEPTICUS 6 0.0005
356 HUMAN HERPESVIRUS 6 INFECTION 1 0.0005
357 BONE MARROW TRANSPLANT 1 0.0005
358 HYPOPROTEINAEMIA 1 0.0005
359 MYELOPATHY 1 0.0005
360 TROPONIN INCREASED 4 0.0005
361 CONJUNCTIVAL HAEMORRHAGE 2 0.0005
362 RETINAL OEDEMA 1 0.0005
363 DIFFUSE LARGE B-CELL LYMPHOMA 4 0.0005
364 RHEUMATIC DISORDER 1 0.0005
365 PERIPHERAL SENSORY NEUROPATHY 3 0.0005
366 ATAXIA 6 0.0005
367 DIPLEGIA 1 0.0005
368 GENE MUTATION 1 0.0005
369 COVID-19 88 0.0005
370 UPPER RESPIRATORY TRACT INFECTION 23 0.0005
371 ORGAN FAILURE 2 0.0005
372 FOAMING AT MOUTH 1 0.0005
373 LYMPHOPENIA 7 0.0005
374 NEUTROPHIL COUNT DECREASED 20 0.0005
375 OSTEOLYSIS 1 0.0005
376 QUADRIPLEGIA 1 0.0005
377 AKINESIA 1 0.0005
378 ATTENTION DEFICIT HYPERACTIVITY DISORDER 2 0.0005
379 SEPSIS 52 0.0005
380 LYMPHOCYTOSIS 1 0.0005
381 HERPES SIMPLEX 3 0.0005
382 STAPHYLOCOCCAL BACTERAEMIA 2 0.0005
383 PRODUCT PREPARATION ISSUE 3 0.0005
384 DYSPHEMIA 2 0.0005
385 BLOOD CREATINE INCREASED 2 0.0005
386 BACTERIAL TEST POSITIVE 1 0.0004
387 MENINGITIS ASEPTIC 2 0.0004
388 WRONG PRODUCT ADMINISTERED 3 0.0004
389 BONE PAIN 26 0.0004
390 BLOOD LOSS ANAEMIA 1 0.0004
391 VASCULAR DEVICE INFECTION 2 0.0004
392 METASTASES TO MENINGES 1 0.0004
393 PRODUCT PREPARATION ERROR 9 0.0004
394 LICHENOID KERATOSIS 1 0.0004
395 REACTION TO EXCIPIENT 1 0.0004
396 HYPERTRANSAMINASAEMIA 3 0.0004
397 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 1 0.0004
398 ESCHERICHIA BACTERAEMIA 1 0.0004
399 OXYGEN CONSUMPTION INCREASED 1 0.0004
400 MYELODYSPLASTIC SYNDROME 6 0.0004
401 ENTEROCOCCAL INFECTION 2 0.0004
402 LYMPHADENITIS 1 0.0004
403 THROMBOTIC MICROANGIOPATHY 4 0.0004
404 ENCEPHALOPATHY 10 0.0004
405 STAPHYLOCOCCAL SEPSIS 2 0.0004
406 HYPERVOLAEMIA 2 0.0004
407 HEPATOTOXICITY 9 0.0004
408 THROMBOCYTOPENIA 45 0.0004
409 PERSECUTORY DELUSION 1 0.0004
410 ERYSIPELAS 2 0.0004
411 METASTASES TO PERITONEUM 1 0.0004
412 INJECTION SITE REACTION 27 0.0004
413 CANCER PAIN 1 0.0004
414 PRODUCT TEMPERATURE EXCURSION ISSUE 2 0.0004
415 AORTIC ARTERIOSCLEROSIS 1 0.0004
416 HERNIA REPAIR 1 0.0004
417 ACUTE MYELOID LEUKAEMIA 6 0.0004
418 TONSILLITIS 2 0.0004
419 PSYCHOMOTOR SKILLS IMPAIRED 1 0.0004
420 ADVERSE EVENT 35 0.0004
421 BLOOD LACTIC ACID INCREASED 2 0.0004
422 SARS-COV-2 TEST POSITIVE 5 0.0004
423 AGRANULOCYTOSIS 7 0.0004
424 LIVER FUNCTION TEST INCREASED 8 0.0004
425 UVEITIS 5 0.0004
426 SHOCK HAEMORRHAGIC 3 0.0004
427 ORAL FUNGAL INFECTION 1 0.0004
428 INTENTIONAL PRODUCT USE ISSUE 32 0.0004
429 WHITE BLOOD CELL COUNT INCREASED 14 0.0004
430 MYELOSUPPRESSION 13 0.0004
431 STREPTOCOCCAL INFECTION 2 0.0004
432 SKIN INFECTION 4 0.0004
433 PULMONARY ALVEOLAR HAEMORRHAGE 2 0.0004
434 DRUG TOLERANCE DECREASED 1 0.0004
435 INFUSION SITE ERYTHEMA 3 0.0004
436 RENAL TUBULAR DISORDER 1 0.0004
437 RESPIRATORY SYMPTOM 1 0.0004
438 NEUROLOGICAL SYMPTOM 2 0.0003
439 HEART VALVE INCOMPETENCE 1 0.0003
440 MYOCARDITIS 4 0.0003
441 RETINAL VEIN OCCLUSION 1 0.0003
442 PHARYNGEAL DISORDER 1 0.0003
443 HERPES VIRUS INFECTION 2 0.0003
444 PARAPLEGIA 1 0.0003
445 HYPERTONIC BLADDER 1 0.0003
446 EYELID MARGIN CRUSTING 1 0.0003
447 DYSPNOEA AT REST 1 0.0003
448 TASTE DISORDER 7 0.0003
449 HAEMOTHORAX 1 0.0003
450 JOINT STIFFNESS 9 0.0003
451 IMMUNOSUPPRESSION 3 0.0003
452 PLEURISY 2 0.0003
453 POLYNEUROPATHY 4 0.0003
454 PLATELET COUNT ABNORMAL 2 0.0003
455 VIRAL INFECTION 11 0.0003
456 PORTAL HYPERTENSION 1 0.0003
457 NEPHROPATHY 3 0.0003
458 BRAIN FOG 5 0.0003
459 BREAST CANCER RECURRENT 1 0.0003
460 HAEMATOTOXICITY 3 0.0003
461 BILE DUCT STONE 1 0.0003
462 HYPERSOMNIA 9 0.0003
463 SUPRAVENTRICULAR TACHYCARDIA 3 0.0003
464 HAEMOGLOBIN ABNORMAL 2 0.0003
465 PORTAL VEIN THROMBOSIS 1 0.0003
466 ANTINUCLEAR ANTIBODY POSITIVE 1 0.0003
467 POLYP 2 0.0003
468 THERAPY CHANGE 3 0.0003
469 PANCYTOPENIA 17 0.0003
470 INFUSION SITE HAEMORRHAGE 1 0.0003
471 CARDIAC FAILURE ACUTE 2 0.0003
472 ANXIETY DISORDER 1 0.0003
473 PRODUCT LABEL ISSUE 2 0.0003
474 HEPATIC CYST 1 0.0003
475 BLOOD TESTOSTERONE DECREASED 2 0.0003
476 NERVOUS SYSTEM DISORDER 9 0.0003
477 MENTAL STATUS CHANGES 8 0.0003
478 DERMATITIS EXFOLIATIVE GENERALISED 1 0.0003
479 HANGOVER 1 0.0003
480 PNEUMONIA 92 0.0003
481 FACIAL PARESIS 1 0.0003
482 VISUAL FIELD DEFECT 2 0.0003
483 ORAL DISORDER 2 0.0003
484 PYREXIA 94 0.0003
485 LEUKOENCEPHALOPATHY 1 0.0003
486 MALNUTRITION 3 0.0003
487 PEMPHIGOID 2 0.0003
488 CATHETER SITE INFECTION 1 0.0003
489 CHEMOTHERAPY 1 0.0003
490 FACE INJURY 1 0.0003
491 ACIDOSIS 2 0.0003
492 ACUTE RESPIRATORY FAILURE 5 0.0003
493 MUSCLE RUPTURE 1 0.0003
494 BASAL CELL CARCINOMA 4 0.0003
495 THERAPY CESSATION 13 0.0003
496 AZOTAEMIA 1 0.0003
497 FUNGAL SKIN INFECTION 1 0.0002
498 C-REACTIVE PROTEIN INCREASED 9 0.0002
499 THERAPY NON-RESPONDER 11 0.0002
500 GLOMERULAR FILTRATION RATE DECREASED 3 0.0002
501 DEMYELINATION 1 0.0002
502 ARTHRITIS BACTERIAL 1 0.0002
503 FUNGAL INFECTION 8 0.0002
504 COGNITIVE DISORDER 11 0.0002
505 HEPATIC CYTOLYSIS 3 0.0002
506 FEBRILE BONE MARROW APLASIA 1 0.0002
507 ADVERSE DRUG REACTION 21 0.0002
508 HEPATIC LESION 1 0.0002
509 MONOPLEGIA 1 0.0002
510 PULMONARY FUNCTION TEST DECREASED 1 0.0002
511 DISEASE PROGRESSION 27 0.0002
512 ORAL CANDIDIASIS 3 0.0002
513 SPINAL OSTEOARTHRITIS 2 0.0002
514 OFF LABEL USE 199 0.0002
515 FEBRILE NEUTROPENIA 15 0.0002
516 ANAEMIA 43 0.0002
517 LUNG DISORDER 11 0.0002
518 HAEMOLYTIC ANAEMIA 2 0.0002
519 ANAL INCONTINENCE 2 0.0002
520 PNEUMONITIS 6 0.0002
521 IMMUNE THROMBOCYTOPENIA 1 0.0002
522 CENTRAL NERVOUS SYSTEM LESION 3 0.0002
523 BRAIN NEOPLASM 2 0.0002
524 ISCHAEMIA 1 0.0002
525 EYE OPERATION 1 0.0002
526 INTERCEPTED MEDICATION ERROR 1 0.0002
527 DISSEMINATED INTRAVASCULAR COAGULATION 3 0.0002
528 CARDIAC FAILURE 17 0.0002
529 DIALYSIS 3 0.0002
530 COLITIS MICROSCOPIC 1 0.0002
531 CARDIAC TAMPONADE 1 0.0002
532 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 2 0.0002
533 CARDIOGENIC SHOCK 3 0.0002
534 HUMERUS FRACTURE 1 0.0002
535 GASTROENTERITIS 3 0.0002
536 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 37 0.0002
537 CHILLS 24 0.0002
538 LABORATORY TEST ABNORMAL 6 0.0002
539 ORGANISING PNEUMONIA 1 0.0002
540 HOSPITALISATION 31 0.0002
541 DELIRIUM 7 0.0002
542 AGEUSIA 5 0.0002
543 PNEUMONIA ASPIRATION 5 0.0002
544 HYPERAMMONAEMIA 1 0.0002
545 CORONARY ARTERY STENOSIS 1 0.0002
546 APHASIA 6 0.0002
547 PRODUCT ADMINISTRATION ERROR 4 0.0002
548 MOTOR DYSFUNCTION 2 0.0002
549 AMMONIA INCREASED 1 0.0002
550 CEREBRAL HAEMORRHAGE 7 0.0002
551 ENDOCARDITIS 1 0.0002
552 DEVICE RELATED INFECTION 3 0.0002
553 CACHEXIA 1 0.0002
554 CEREBRAL ISCHAEMIA 1 0.0002
555 INJECTION SITE PRURITUS 13 0.0002
556 PRODUCT DOSE OMISSION ISSUE 57 0.0002
557 EYE DISCHARGE 2 0.0002
558 CONFUSIONAL STATE 31 0.0002
559 INCONTINENCE 2 0.0002
560 INFLUENZA 21 0.0002
561 COMPRESSION FRACTURE 1 0.0002
562 INTESTINAL RESECTION 1 0.0002
563 GINGIVITIS 1 0.0002
564 HAEMOGLOBIN DECREASED 19 0.0002
565 HIP SURGERY 1 0.0002
566 HYDROCEPHALUS 1 0.0002
567 DEAFNESS UNILATERAL 1 0.0002
568 PLEURAL EFFUSION 11 0.0002
569 DEATH 155 0.0002
570 RASH MACULO-PAPULAR 4 0.0002
571 NECROSIS 1 0.0002
572 DEMENTIA 5 0.0002
573 PLATELET COUNT DECREASED 19 0.0002
574 INTESTINAL PERFORATION 2 0.0002
575 CANDIDA INFECTION 3 0.0002
576 EYE INFECTION 2 0.0002
577 HEMIPARESIS 3 0.0002
578 MULTIPLE ORGAN DYSFUNCTION SYNDROME 5 0.0002
579 GRANULOCYTOPENIA 1 0.0002
580 WHITE BLOOD CELL COUNT DECREASED 19 0.0002
581 CARDIAC VALVE DISEASE 1 0.0002
582 ENTEROCOLITIS 1 0.0002
583 PRODUCT LABEL CONFUSION 1 0.0002
584 SPINAL PAIN 2 0.0002
585 HYPOXIA 6 0.0002
586 ACUTE RESPIRATORY DISTRESS SYNDROME 3 0.0002
587 BRADYKINESIA 1 0.0002
588 INJECTION SITE ERYTHEMA 21 0.0002
589 ISCHAEMIC STROKE 3 0.0002
590 PRODUCTIVE COUGH 8 0.0002
591 HEPATITIS CHOLESTATIC 1 0.0002
592 HEPATITIS B 1 0.0002
593 OSTEOMYELITIS 3 0.0002
594 RESTLESS LEGS SYNDROME 3 0.0002
595 RESPIRATORY FAILURE 12 0.0002
596 HYPOTENSION 33 0.0002
597 INTERCEPTED PRODUCT PREPARATION ERROR 2 0.0002
598 BLOOD ALKALINE PHOSPHATASE INCREASED 4 0.0002
599 TUBULOINTERSTITIAL NEPHRITIS 3 0.0002
600 CELLULITIS 8 0.0002
601 CHOLESTASIS 3 0.0002
602 PROCTALGIA 1 0.0002
603 HEPATITIS ACUTE 1 0.0002
604 BLOOD PRESSURE SYSTOLIC INCREASED 3 0.0002
605 BRADYPHRENIA 1 0.0002
606 KIDNEY INFECTION 3 0.0002
607 IMMUNE SYSTEM DISORDER 2 0.0002
608 DEPRESSED LEVEL OF CONSCIOUSNESS 6 0.0002
609 MENINGITIS 1 0.0001
610 LEFT VENTRICULAR DYSFUNCTION 1 0.0001
611 THERAPEUTIC RESPONSE DECREASED 9 0.0001
612 BRONCHIECTASIS 1 0.0001
613 BLOOD BILIRUBIN INCREASED 4 0.0001
614 GENERAL PHYSICAL HEALTH DETERIORATION 17 0.0001
615 TACHYCARDIA 13 0.0001
616 NEPHROTIC SYNDROME 1 0.0001
617 PERITONITIS 3 0.0001
618 DERMATITIS 3 0.0001
619 LEUKOPENIA 7 0.0001
620 SUBDURAL HAEMATOMA 2 0.0001
621 SKIN CANCER 3 0.0001
622 ANOSMIA 2 0.0001
623 HYPOKINESIA 2 0.0001
624 DYSPHONIA 8 0.0001
625 SINUSITIS 14 0.0001
626 MOUTH HAEMORRHAGE 1 0.0001
627 ATRIAL FIBRILLATION 13 0.0001
628 PANCREATITIS ACUTE 3 0.0001
629 GENERAL SYMPTOM 1 0.0001
630 LOWER RESPIRATORY TRACT INFECTION 6 0.0001
631 HEPATOCELLULAR CARCINOMA 1 0.0001
632 APHTHOUS ULCER 1 0.0001
633 EJECTION FRACTION DECREASED 2 0.0001
634 HYPOALBUMINAEMIA 1 0.0001
635 PELVIC FRACTURE 1 0.0001
636 HAEMORRHAGIC STROKE 1 0.0001
637 GASTROINTESTINAL INFLAMMATION 1 0.0001
638 MULTIPLE ALLERGIES 1 0.0001
639 FATIGUE 99 0.0001
640 DISORIENTATION 5 0.0001
641 RENAL CYST 1 0.0001
642 ATRIAL FLUTTER 1 0.0001
643 METABOLIC ACIDOSIS 4 0.0001
644 BLOOD DISORDER 1 0.0001
645 ACUTE KIDNEY INJURY 19 0.0001
646 BLOOD POTASSIUM INCREASED 2 0.0001
647 POST PROCEDURAL INFECTION 1 0.0001
648 ASPHYXIA 1 0.0001
649 HICCUPS 1 0.0001
650 WEIGHT DECREASED 34 0.0001
651 ACUTE CORONARY SYNDROME 1 0.0001
652 RENAL FAILURE 16 0.0001
653 EMBOLISM 1 0.0001
654 HEMIPLEGIA 1 0.0001
655 UPPER GASTROINTESTINAL HAEMORRHAGE 2 0.0001
656 CIRCULATORY COLLAPSE 2 0.0001
657 FACIAL PARALYSIS 1 0.0001
658 UNRESPONSIVE TO STIMULI 3 0.0001
659 ANURIA 1 0.0001
660 BLOOD MAGNESIUM DECREASED 1 0.0001
661 PULMONARY EMBOLISM 11 0.0001
662 DIPLOPIA 3 0.0001
663 EOSINOPHILIA 2 0.0001
664 GRIP STRENGTH DECREASED 1 0.0001
665 LUNG INFILTRATION 1 0.0001
666 LYMPHOCYTE COUNT DECREASED 2 0.0001
667 EAR INFECTION 3 0.0001
668 CARDIOTOXICITY 1 0.0001
669 THROMBOSIS 9 0.0001
670 OEDEMA 6 0.0001
671 TOOTHACHE 2 0.0001
672 OPTIC NEURITIS 1 0.0001
673 IRON DEFICIENCY ANAEMIA 1 0.0001
674 HYPOKALAEMIA 5 0.0001
675 BRONCHITIS 8 0.0001
676 CONJUNCTIVITIS 2 0.0001
677 HAEMOPTYSIS 3 0.0001
678 BLOOD CREATININE INCREASED 7 0.0001
679 HEPATIC FUNCTION ABNORMAL 4 0.0001
680 RENAL IMPAIRMENT 9 0.0001
681 DIARRHOEA HAEMORRHAGIC 1 0.0001
682 COUGH 30 0.0001
683 HEPATIC CIRRHOSIS 2 0.0001
684 LEUKAEMIA 1 0.0001
685 HYPOCALCAEMIA 2 0.0001
686 MUSCULAR WEAKNESS 12 0.0001
687 ARRHYTHMIA 5 0.0001
688 DECREASED APPETITE 24 0.0001
689 DIZZINESS POSTURAL 1 0.0001
690 HEPATIC ENZYME INCREASED 7 0.0001
691 PARKINSONISM 1 0.0001
692 ASCITES 3 0.0001
693 SINUS DISORDER 2 0.0001
694 DIARRHOEA 65 0.0001
695 BLOOD PRESSURE ABNORMAL 2 0.0001
696 RESPIRATORY DISORDER 3 0.0001
697 HYPOTONIA 1 0.0001
698 BRAIN INJURY 1 0.0001
699 FULL BLOOD COUNT DECREASED 2 0.0001
700 EMPHYSEMA 1 0.0001
701 BONE MARROW FAILURE 2 0.0001
702 BODY TEMPERATURE INCREASED 2 0.0001
703 NEUTROPHIL COUNT INCREASED 1 0.0001
704 INITIAL INSOMNIA 1 0.0001
705 RIB FRACTURE 2 0.0001
706 ILLNESS 10 0.0001
707 CARDIAC ARREST 8 0.0001
708 RASH 42 0.0001
709 ECZEMA 5 0.0001
710 DYSGEUSIA 7 0.0001
711 CYSTITIS 3 0.0001
712 URINARY TRACT INFECTION 16 0.0001
713 NIGHT SWEATS 3 0.0001
714 ASTHENIA 35 0.0001
715 DECREASED ACTIVITY 1 0.0001
716 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
717 AMNESIA 6 0.0001
718 PRODUCT DISPENSING ERROR 2 0.0001
719 TREATMENT NONCOMPLIANCE 5 0.0001
720 INJECTION SITE SWELLING 7 0.0001
721 STAPHYLOCOCCAL INFECTION 3 0.0001
722 GASTROINTESTINAL PAIN 1 0.0001
723 INJECTION SITE NODULE 1 0.0001
724 TREMOR 15 0.0001
725 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
726 NERVE INJURY 1 0.0001
727 HYPERTENSIVE CRISIS 1 0.0001
728 THERAPEUTIC PRODUCT EFFECT DECREASED 4 0.0001
729 OXYGEN SATURATION DECREASED 5 0.0001
730 BLOOD CALCIUM DECREASED 1 0.0001
731 CHOLECYSTECTOMY 1 0.0001
732 NEPHROLITHIASIS 4 0.0001
733 SHOCK 2 0.0001
734 SEIZURE 10 0.0001
735 DRY MOUTH 7 0.0001
736 ELECTROLYTE IMBALANCE 1 0.0001
737 POST PROCEDURAL HAEMORRHAGE 1 0.0001
738 HYPERKALAEMIA 3 0.0001
739 CHOLECYSTITIS 1 0.0001
740 ACCIDENT 1 0.0001
741 STOMATITIS 5 0.0001
742 NEURALGIA 2 0.0001
743 CEREBRAL INFARCTION 2 0.0001
744 ILEUS 1 0.0001
745 DRY EYE 4 0.0001
746 BRAIN OEDEMA 1 0.0001
747 MUSCLE ATROPHY 1 0.0001
748 INJECTION SITE IRRITATION 1 0.0001
749 HEPATITIS 2 0.0001
750 INFUSION SITE PAIN 1 0.0001
751 PLATELET COUNT INCREASED 1 0.0001
752 NODULE 1 0.0001
753 DEAFNESS 2 0.0001
754 MUSCULOSKELETAL PAIN 4 0.0001
755 NASOPHARYNGITIS 14 0.0001
756 DEPRESSED MOOD 4 0.0001
757 INFUSION RELATED REACTION 5 0.0001
758 MALIGNANT MELANOMA 1 0.0001
759 QUALITY OF LIFE DECREASED 1 0.0001
760 OEDEMA PERIPHERAL 9 0.0001
761 DYSPHAGIA 7 0.0001
762 ACUTE HEPATIC FAILURE 1 0.0001
763 SKIN LESION 2 0.0001
764 PERIPHERAL COLDNESS 1 0.0001
765 RESPIRATORY DISTRESS 2 0.0001
766 DIVERTICULITIS 2 0.0001
767 HYPOMAGNESAEMIA 1 0.0001
768 HUNGER 1 0.0001
769 DEVICE OCCLUSION 1 0.0001
770 BLINDNESS UNILATERAL 1 0.0001
771 HEPATOCELLULAR INJURY 1 0.0001
772 PARALYSIS 1 0.0001
773 ANGINA PECTORIS 2 0.0001
774 HYPOACUSIS 3 0.0001
775 HERPES ZOSTER 4 0.0001
776 LETHARGY 4 0.0001
777 PARAESTHESIA ORAL 1 0.0001
778 INJECTION SITE HAEMATOMA 1 0.0001
779 APATHY 1 0.0001
780 MALIGNANT NEOPLASM PROGRESSION 7 0.0001
781 NASAL CONGESTION 4 0.0001
782 GAIT DISTURBANCE 13 0.0001
783 CARDIOMYOPATHY 1 0.0001
784 LIVER DISORDER 3 0.0001
785 PULMONARY MASS 1 0.0001
786 PULMONARY OEDEMA 3 0.0001
787 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
788 HYPOAESTHESIA ORAL 1 0.0001
789 HEADACHE 41 0.0001
790 PRODUCT USE COMPLAINT 1 0.0001
791 HEAD INJURY 2 0.0001
792 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
793 PNEUMOTHORAX 1 0.0001
794 COMA 3 0.0001
795 RESPIRATORY TRACT CONGESTION 1 0.0001
796 MIGRAINE 6 0.0001
797 RASH ERYTHEMATOUS 3 0.0001
798 ABSCESS 1 0.0001
799 HIP FRACTURE 2 0.0001
800 INTERSTITIAL LUNG DISEASE 3 0.0001
801 RHINORRHOEA 4 0.0001
802 MUSCLE TIGHTNESS 1 0.0001
803 BACK DISORDER 1 0.0001
804 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
805 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
806 BLOOD PRESSURE DECREASED 4 0.0001
807 HYPOAESTHESIA 9 0.0001
808 COAGULOPATHY 1 0.0001
809 DEHYDRATION 8 0.0001
810 SKIN DISORDER 2 0.0001
811 URINARY RETENTION 2 0.0001
812 GAIT INABILITY 2 0.0001
813 PERICARDITIS 1 0.0001
814 CEREBROVASCULAR ACCIDENT 10 0.0001
815 INFLAMMATION 3 0.0001
816 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3 0.0001
817 HAEMORRHAGE 6 0.0001
818 HEAD DISCOMFORT 1 0.0001
819 ASPARTATE AMINOTRANSFERASE INCREASED 3 0.0001
820 THERAPY INTERRUPTED 4 0.0001
821 BACK PAIN 13 0.0001
822 GASTROINTESTINAL DISORDER 5 0.0001
823 MOBILITY DECREASED 4 0.0001
824 DRUG INEFFECTIVE 73 0.0001
825 GASTROENTERITIS VIRAL 1 0.0001
826 ARTHRALGIA 23 0.0001
827 DYSPNOEA 31 0.0001
828 RESTLESSNESS 2 0.0001
829 DYSURIA 2 0.0001
830 ARTHROPATHY 3 0.0001
831 HEPATIC STEATOSIS 1 0.0001
832 ERYTHEMA 11 0.0001
833 CARDIAC DISORDER 5 0.0001
834 PHOTOPHOBIA 1 0.0001
835 DYSARTHRIA 2 0.0001
836 DYSPNOEA EXERTIONAL 2 0.0001
837 HALLUCINATION 4 0.0001
838 FRACTURE 1 0.0001
839 FOOT FRACTURE 1 0.0001
840 INCREASED APPETITE 1 0.0001
841 PULMONARY FIBROSIS 1 0.0001
842 HERNIA 1 0.0001
843 EAR PAIN 1 0.0001
844 MEMORY IMPAIRMENT 7 0.0001
845 INJECTION SITE HAEMORRHAGE 4 0.0001
846 SYNCOPE 5 0.0000
847 FEEDING DISORDER 1 0.0000
848 DISCOMFORT 3 0.0000
849 PAIN 30 0.0000
850 LUNG NEOPLASM MALIGNANT 2 0.0000
851 INFLUENZA LIKE ILLNESS 4 0.0000
852 SKIN EXFOLIATION 4 0.0000
853 JOINT INJURY 1 0.0000
854 NAUSEA 37 0.0000
855 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
856 PRODUCT STORAGE ERROR 4 0.0000
857 MELAENA 1 0.0000
858 FALL 15 0.0000
859 NEOPLASM MALIGNANT 3 0.0000
860 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 9 0.0000
861 APPLICATION SITE PRURITUS 1 0.0000
862 MUSCLE SPASMS 8 0.0000
863 PERICARDIAL EFFUSION 1 0.0000
864 RENAL DISORDER 2 0.0000
865 HYPERTENSION 9 0.0000
866 OCULAR HYPERAEMIA 2 0.0000
867 PRODUCT PRESCRIBING ERROR 1 0.0000
868 BLOOD PRESSURE FLUCTUATION 1 0.0000
869 HEPATIC CANCER 1 0.0000
870 LOCALISED INFECTION 1 0.0000
871 CONSTIPATION 9 0.0000
872 MENTAL IMPAIRMENT 1 0.0000
873 LIVER INJURY 1 0.0000
874 OSTEONECROSIS OF JAW 1 0.0000
875 HEART RATE INCREASED 4 0.0000
876 EPISTAXIS 3 0.0000
877 PRODUCT COMPLAINT 1 0.0000
878 HYPOPHAGIA 1 0.0000
879 LOSS OF CONSCIOUSNESS 5 0.0000
880 PERIPHERAL SWELLING 6 0.0000
881 ANAPHYLACTIC SHOCK 1 0.0000
882 HAEMATOMA 1 0.0000
883 VOMITING 18 0.0000
884 MUCOSAL INFLAMMATION 1 0.0000
885 GASTRITIS 1 0.0000
886 BRADYCARDIA 2 0.0000
887 CARDIAC FAILURE CONGESTIVE 3 0.0000
888 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
889 RESPIRATORY ARREST 1 0.0000
890 TREATMENT FAILURE 3 0.0000
891 MEDICATION ERROR 2 0.0000
892 BLISTER 2 0.0000
893 EYE PAIN 2 0.0000
894 PAIN IN JAW 1 0.0000
895 MYALGIA 6 0.0000
896 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
897 RED BLOOD CELL COUNT DECREASED 1 0.0000
898 EYE IRRITATION 2 0.0000
899 PANCREATIC CARCINOMA 1 0.0000
900 MYOCARDIAL INFARCTION 6 0.0000
901 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
902 PSYCHOTIC DISORDER 1 0.0000
903 WHEEZING 2 0.0000
904 CATARACT 2 0.0000
905 BLOOD POTASSIUM DECREASED 1 0.0000
906 HEPATIC FAILURE 1 0.0000
907 CORONARY ARTERY DISEASE 1 0.0000
908 SUICIDE ATTEMPT 2 0.0000
909 FEELING HOT 2 0.0000
910 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
911 EMOTIONAL DISORDER 1 0.0000
912 OROPHARYNGEAL PAIN 3 0.0000
913 CHEST PAIN 6 0.0000
914 FEMUR FRACTURE 1 0.0000
915 SWELLING 3 0.0000
916 MALAISE 14 0.0000
917 HYPOTHYROIDISM 1 0.0000
918 INTENTIONAL OVERDOSE 2 0.0000
919 MOVEMENT DISORDER 1 0.0000
920 DRUG INTOLERANCE 3 0.0000
921 LACTIC ACIDOSIS 1 0.0000
922 DEPRESSION 7 0.0000
923 PAIN IN EXTREMITY 9 0.0000
924 CHOLELITHIASIS 1 0.0000
925 EYE DISORDER 1 0.0000
926 ABDOMINAL DISCOMFORT 5 0.0000
927 SOMNOLENCE 6 0.0000
928 CHEST DISCOMFORT 3 0.0000
929 HAEMATURIA 1 0.0000
930 NIGHTMARE 1 0.0000
931 HEART RATE DECREASED 1 0.0000
932 LYMPHADENOPATHY 1 0.0000
933 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
934 DIZZINESS 14 0.0000
935 CRYING 1 0.0000
936 HYPERGLYCAEMIA 1 0.0000
937 PANIC ATTACK 1 0.0000
938 ACCIDENTAL OVERDOSE 1 0.0000
939 AGITATION 2 0.0000
940 INJECTION SITE MASS 1 0.0000
941 HYPERSENSITIVITY 5 0.0000
942 EYE SWELLING 1 0.0000
943 CHRONIC KIDNEY DISEASE 2 0.0000
944 INCORRECT DOSE ADMINISTERED 6 0.0000
945 INJECTION SITE PAIN 8 0.0000
946 PRURITUS 10 0.0000
947 PARAESTHESIA 4 0.0000
948 INJECTION SITE BRUISING 2 0.0000
949 EXTRA DOSE ADMINISTERED 1 0.0000
950 DYSKINESIA 1 0.0000
951 BLINDNESS 1 0.0000
952 OSTEOPOROSIS 1 0.0000
953 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
954 CARDIO-RESPIRATORY ARREST 1 0.0000
955 ROAD TRAFFIC ACCIDENT 1 0.0000
956 TOXICITY TO VARIOUS AGENTS 4 0.0000
957 HYPERHIDROSIS 3 0.0000
958 MENTAL DISORDER 1 0.0000
959 MUSCULOSKELETAL STIFFNESS 2 0.0000
960 COLITIS ULCERATIVE 1 0.0000
961 BREAST CANCER 2 0.0000
962 DISEASE RECURRENCE 1 0.0000
963 RENAL CANCER 1 0.0000
964 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
965 AGGRESSION 1 0.0000
966 BLOOD PRESSURE INCREASED 3 0.0000
967 INSOMNIA 5 0.0000
968 RASH PRURITIC 1 0.0000
969 URTICARIA 3 0.0000
970 NECK PAIN 1 0.0000
971 HYPONATRAEMIA 1 0.0000
972 FLATULENCE 1 0.0000
973 RHEUMATOID ARTHRITIS 2 0.0000
974 FEELING ABNORMAL 4 0.0000
975 VISUAL IMPAIRMENT 2 0.0000
976 PRODUCT USE ISSUE 3 0.0000
977 VISION BLURRED 2 0.0000
978 INJURY 1 0.0000
979 ANXIETY 4 0.0000
980 ABDOMINAL PAIN 3 0.0000
981 PRODUCT USE IN UNAPPROVED INDICATION 3 0.0000
982 BALANCE DISORDER 1 0.0000
983 CONTUSION 1 0.0000
984 DYSPEPSIA 1 0.0000
985 CONDITION AGGRAVATED 3 0.0000
986 FLUSHING 1 0.0000
987 ABDOMINAL PAIN UPPER 2 0.0000
988 ABDOMINAL DISTENSION 1 0.0000
989 WEIGHT INCREASED 2 0.0000
990 EMOTIONAL DISTRESS 1 0.0000
991 DRY SKIN 1 0.0000
992 DRUG INTERACTION 1 0.0000